Oral leukoplakias show numerical chromosomal aberrations detected by fluorescence in situ hybridization

Laryngoscope

Volumn 108, Issue 6, 1998, Pages 917-922

  Lenz, Christian F ^a   Pfuhl, Andreas ^a   Finckh, Martin ^a   Weidauer, Hagen ^a   Bosch, Franz X ^a  

^a UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANCER RISK; CHROMOSOME ABERRATION; DIAGNOSTIC VALUE; FLUORESCENCE IN SITU HYBRIDIZATION; HUMAN; HUMAN CELL; HUMAN TISSUE; LEUKOPLAKIA; PRIORITY JOURNAL;

ADOLESCENT; ADULT; AGED; BIOPSY; CHROMOSOME ABERRATIONS; CHROMOSOME DISORDERS; CHROMOSOMES, HUMAN, PAIR 1; CHROMOSOMES, HUMAN, PAIR 10; CHROMOSOMES, HUMAN, PAIR 17; CHROMOSOMES, HUMAN, PAIR 7; FOLLOW-UP STUDIES; HEAD AND NECK NEOPLASMS; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; LEUKOPLAKIA; MIDDLE AGED;

EID: 0031807643     PISSN: 0023852X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005537-199806000-00023     Document Type: Article

References (28)

1. Rothman K, Keller A. The effects of joint exposure to alcohol and tobacco on risk of cancer of the mouth and pharynx. J Chron Dis 1972;25:711-6.
2. Cann CI, Fried MP, Rothman KJ. Epidemiology of squamous cell cancer of the head and neck. Otolaryngol Clin 1985;18:1-22.
3. Hittelman WN, Voravud N, Shin DM, et al. Early genetic changes during upper aerodigestive tract tumorigenesis. J Cell Biochem 1993;17F:233-6.
4. Soder AI, Hopman AHN, Ramaekers FCS, et al. Distinct non-random patterns of chromosomal aberrations in the progression of squamous cell carcinomas of the head and neck. Cancer Res 1995;55:5030-7.
5. Hong WK, Endicott J, Itri LM, et al. 13-cis-Retinoic acid in the treatment of oral leukoplakia. N Engl J Med 1986;315: 1501-5.
6. Hong WK, Lippman SM, Itri LM, et al. Prevention of second primary tumors with isotretinoin in squamous cell carcinoma of the head and neck. N Engl J Med 1990;323: 795-801.
7. Nees M, Homann N, Discher H, et al. Expression of mutated p53 occurs in tumor-distant epithelia of head and neck cancer patients: a possible molecular basis for the development of multiple tumors. Cancer Res 1993;53:4189-96.
8. Stich HF. Micronucleated exfoliated cells as indicators for genotoxic damage and as markers in chemoprevention trials. J Nutr Growth Cancer 1987;4:9-18.
9. Van Dyke DL, Worsham MJ, Benninger MS, et al. Recurrent cytogenetic abnormalities in squamous cell carcinomas of the head and neck region. Genes Chromosomes Cancer 1994;9:192-206.
10. Alcaraz A, Takahashi S, Brown JA, et al. Aneuploidy and aneusomy of chromosome 7 detected by fluorescence in situ hybridization are markers of poor prognosis in prostate cancer. Cancer Res 1994;54:3998-4002.
11. Hopman AHN, Voorter CEM, Ramaekers FCS. Detection of genomic changes in cancer by in situ hybridization. Mol Biol Rep 1994;19:31-44.
12. Cooke HJ, Hindley J. Cloning of human satellite III DNA: different components are on different chromosomes. Nucleic Acids Res 1979;6:3177-83.
13. Waye JS, Creeper LA, Willard HF. Organization and evolution of alpha satellite DNA from human chromosome 11. Chromosoma 1987;95:182-8.
14. Moyzis RK, Albright KL, Bartholdi MF, et al. Human chromosome-specific repetitive DNA sequences: novel markers for genetic analysis. Chromosoma 1987;95:375-82.
15. Waye JS, Willard HF. Molecular analysis of a deletion polymorphism in alpha satellite of human chromosome 17: evidence for homologous unequal crossing-over and subsequent fixation. Nucleic Acids Res 1986;14:6915-21.
16. Hopman AHN, Ramaekers FCS, Raap AK, et al. In situ hybridization as a tool to study numerical chromosome aberrations in solid bladder tumors. Histochemistry 1988;89:307-16.
17. Hopman AHN, Poddighe PJ, Smeets WGB, et al. Detection of numerical aberrations in bladder cancer by in situ hybridization. Am J Pathol 1989;135:1105-17.
18. Hopman AHN, Moesker O, Smeets WGB, et al. Numerical chromosome 1, 7, 9, and 11 aberrations in bladder cancer detected by in situ hybridization. Cancer Res 1991;51: 644-51.
19. Pinkel D, Straume T, Gray J. Cytogenetic analysis using quantitative, high-sensitivity, fluorescence hybridization. Proc Natl Acad Sci U S A 1986;83:2934-8.
20. Van Dekken H, Bauman JGJ. A new application of in situ hybridization: detection of numerical and structural chromosome aberrations with a combination centromeric-telomeric DNA probe. Cytogenet Cell Genet 1989;78:251-9.
21. Veltman JA, Hopman AHN, Bot FJ, et al. Detection of chromosomal aberrations in cytological brushes from head and neck squamous cell carcinoma. Cancer Cytopathol, 1997; 81:309-14.
22. Brennan JA, Mao L, Hruban RH, et al. Molecular assessment of histopathologic staging in squamous cell carcinoma of the head and neck. N Engl J Med 1995;332:429-35.
23. Jacob R, Welkoborsky HJ, Mann WJ, et al. Heterogeneity of SCC of the head and neck: analysis of tumor biologic factors and proliferation rates. Laryngoscope 1996;106: 1170-5.
24. Kahn MA, Dockter ME, Hermann-Petrin JM. Flow cytometric analysis of oral premalignant lesions: a pilot study and review. J Oral Pathol Med 1992;21:1-6.
25. Hellquist H, Oloffson J. Photometric evaluation of laryngeal epithelium exhibiting hyperplasia, keratosis and moderate dysplasia. Acta Otolaryngol 1981;92:157-65.
26. Silverman S, Gorsky M, Lozada F. Oral leukoplakia and malignant transformation. Cancer 1994;53:563-8.
27. Voravud N, Shin DM, Ro JY, et al. Increased polysomies of chromosome 7 and 17 during head and neck multistage tumorigenesis. Cancer Res 1993;53:2874-83.
28. Lee JS, Kim SY, Hong WK, et al. Detection of chromosomal polysomy in oral leukoplakia, a premalignant lesion. J Natl Cancer Inst 1993;23:1951-4.